iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis
- PMID: 24905578
- DOI: 10.1038/ncomms5028
iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis
Abstract
Mutations in the acid β-glucocerebrosidase (GBA1) gene, responsible for the lysosomal storage disorder Gaucher's disease (GD), are the strongest genetic risk factor for Parkinson's disease (PD) known to date. Here we generate induced pluripotent stem cells from subjects with GD and PD harbouring GBA1 mutations, and differentiate them into midbrain dopaminergic neurons followed by enrichment using fluorescence-activated cell sorting. Neurons show a reduction in glucocerebrosidase activity and protein levels, increase in glucosylceramide and α-synuclein levels as well as autophagic and lysosomal defects. Quantitative proteomic profiling reveals an increase of the neuronal calcium-binding protein 2 (NECAB2) in diseased neurons. Mutant neurons show a dysregulation of calcium homeostasis and increased vulnerability to stress responses involving elevation of cytosolic calcium. Importantly, correction of the mutations rescues such pathological phenotypes. These findings provide evidence for a link between GBA1 mutations and complex changes in the autophagic/lysosomal system and intracellular calcium homeostasis, which underlie vulnerability to neurodegeneration.
Similar articles
-
Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model of GBA1-associated Parkinson's disease.Hum Mol Genet. 2023 May 18;32(11):1888-1900. doi: 10.1093/hmg/ddad025. Hum Mol Genet. 2023. PMID: 36752535 Free PMC article.
-
mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cells.Dis Model Mech. 2019 Oct 16;12(10):dmm038596. doi: 10.1242/dmm.038596. Dis Model Mech. 2019. PMID: 31519738 Free PMC article.
-
Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease.Mov Disord. 2016 Nov;31(11):1610-1618. doi: 10.1002/mds.26802. Epub 2016 Sep 13. Mov Disord. 2016. PMID: 27619775 Free PMC article. Review.
-
Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease.Neurobiol Dis. 2019 Feb;122:72-82. doi: 10.1016/j.nbd.2018.03.008. Epub 2018 Mar 14. Neurobiol Dis. 2019. PMID: 29550539 Free PMC article. Review.
-
Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function.Hum Mol Genet. 2018 Jun 1;27(11):1972-1988. doi: 10.1093/hmg/ddy105. Hum Mol Genet. 2018. PMID: 29579237 Free PMC article.
Cited by
-
DJ-1 protects cell death from a mitochondrial oxidative stress due to GBA1 deficiency.Genes Genomics. 2024 Mar 9. doi: 10.1007/s13258-024-01506-w. Online ahead of print. Genes Genomics. 2024. PMID: 38460098
-
GBA1 inactivation in oligodendrocytes affects myelination and induces neurodegenerative hallmarks and lipid dyshomeostasis in mice.Mol Neurodegener. 2024 Mar 7;19(1):22. doi: 10.1186/s13024-024-00713-z. Mol Neurodegener. 2024. PMID: 38454456 Free PMC article.
-
iSCORE-PD: an isogenic stem cell collection to research Parkinson's Disease.bioRxiv [Preprint]. 2024 Feb 13:2024.02.12.579917. doi: 10.1101/2024.02.12.579917. bioRxiv. 2024. PMID: 38405931 Free PMC article. Preprint.
-
Synaptic dysfunction and extracellular matrix dysregulation in dopaminergic neurons from sporadic and E326K-GBA1 Parkinson's disease patients.NPJ Parkinsons Dis. 2024 Feb 19;10(1):38. doi: 10.1038/s41531-024-00653-x. NPJ Parkinsons Dis. 2024. PMID: 38374278 Free PMC article.
-
Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery.Philos Trans R Soc Lond B Biol Sci. 2024 Apr 8;379(1899):20220381. doi: 10.1098/rstb.2022.0381. Epub 2024 Feb 19. Philos Trans R Soc Lond B Biol Sci. 2024. PMID: 38368939 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
